An ex Vivo Model to Study v-Myb-Induced Leukemogenicity

By Dvorakova M.   Kralova J.   Karafiat V.   Bartunek P.   Dvorak M.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 2, 2001-02 ,pp. : 437-445

Academic Press

Access to resources Recommend Favorite

The “ex Vivo” Patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR Expression Identify Acute/Early and Chronic/Late NK-Cell Activation States

By Lima M.   Almeida J.   dos Anjos Teixeira M.   Queirós M.L.   Justiça B.   Orfão A.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 181-190

Academic Press

Access to resources Recommend Favorite

In Vivo Veritas

By Lotze M.T.  

Clinical Immunology, Vol. 93, Iss. 1, 1999-10 ,pp. : 1-4

Academic Press

Access to resources Recommend Favorite

In Vivo Nasal Challenge with Diesel Exhaust Particles Enhances Expression of the CC Chemokines Rantes, MIP-1α, and MCP-3 in Humans

By Diaz-Sanchez D.   Jyrala M.   Ng D.   Nel A.   Saxon A.  

Clinical Immunology, Vol. 97, Iss. 2, 2000-11 ,pp. : 140-145

Academic Press

Access to resources Recommend Favorite

Expression of the Endothelial Markers PECAM-1, vWf, and CD34 in Vivo and in Vitro

By Müller A.M.   Hermanns M.I.   Skrzynski C.   Nesslinger M.   Müller K-M.   Kirkpatrick C.J.  

Experimental and Molecular Pathology, Vol. 72, Iss. 3, 2002-06 ,pp. : 221-229

Academic Press

Access to resources Recommend Favorite